Compass Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CMPX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/16/2023

Compass Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc Director, 10%+ Owner $29.4 M Nov 8, 2022
Thomas J. Schuetz PRESIDENT, Director $9.53 M Feb 8, 2024
Vered Bisker-Leib CHIEF EXECUTIVE OFFICER, Director $4.53 M Feb 8, 2024
Susan Kalled Chief Scientific Officer Feb 18, 2022
Brett Kaplan Director Feb 18, 2022
Philip Ferneau Director Feb 9, 2024
Mary Ann Gray Director Feb 9, 2024
Stephen P. Squinto Director Feb 18, 2022
L. Gordon Director, 10%+ Owner Feb 9, 2024
Ellen Chiniara Director Feb 9, 2024
James P. Boylan Director Mar 8, 2024
David M. Wurzer Director Feb 8, 2023
Miranda Jayne Toledano Director Jun 25, 2021
Richard S. Lindahl Director Feb 9, 2024

Recent Insider Transactions by Companies or Individuals for Compass Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership